Literature DB >> 31626024

A comprehensive review of topical hemostatic agents: The good, the bad, and the novel.

Allison J Tompeck1, Aniq Ur Reham Gajdhar, Matthew Dowling, Steven B Johnson, Philip S Barie, Robert J Winchell, David King, Thomas M Scalea, L D Britt, Mayur Narayan.   

Abstract

Uncontrolled exsanguination remains the leading cause of death for trauma patients, many of whom die in the pre-hospital setting. Without expedient intervention, trauma-associated hemorrhage induces a host of systemic responses and acute coagulopathy of trauma. For this reason, health care providers and prehospital personal face the challenge of swift and effective hemorrhage control. The utilization of adjuncts to facilitate hemostasis was first recorded in 1886. Commercially available products haves since expanded to include topical hemostats, surgical sealants, and adhesives. The ideal product balances efficacy, with safety practicality and cost-effectiveness. This review of hemostasis provides a guide for successful implementation and simultaneously highlights future opportunities.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31626024     DOI: 10.1097/TA.0000000000002508

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  10 in total

Review 1.  Topical hemostatic agents in neurosurgery, a comprehensive review: 15 years update.

Authors:  C Schonauer; C Mastantuoni; T Somma; R de Falco; P Cappabianca; E Tessitore
Journal:  Neurosurg Rev       Date:  2021-11-04       Impact factor: 3.042

Review 2.  Facing Trauma and Surgical Emergency in Space: Hemorrhagic Shock.

Authors:  D Pantalone; O Chiara; S Henry; S Cimbanassi; S Gupta; T Scalea
Journal:  Front Bioeng Biotechnol       Date:  2022-07-01

Review 3.  Biomaterials for Hemostasis.

Authors:  Aryssa Simpson; Anita Shukla; Ashley C Brown
Journal:  Annu Rev Biomed Eng       Date:  2022-03-01       Impact factor: 11.324

4.  Hemostatic Efficacy of Absorbable Gelatin Sponges for Surgical Nail Matrixectomy after Phenolization-A Blinded Randomized Controlled Trial.

Authors:  Antonio Córdoba-Fernández; Adrián Lobo-Martín
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

5.  Design and Preclinical Evaluation of Chitosan/Kaolin Nanocomposites with Enhanced Hemostatic Efficiency.

Authors:  Mahmoud Elsabahy; Mostafa A Hamad
Journal:  Mar Drugs       Date:  2021-01-22       Impact factor: 5.118

6.  The Use of Hemostatic Agents to Decrease Bleeding Complications in General Plastic Surgery Procedures.

Authors:  Joshua A Bloom; Zachary Erlichman; Sina Foroutanjazi; Zhaneta Beqiraj; Michael M Jonczyk; Sarah M Persing; Abhishek Chatterjee
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-08-19

Review 7.  Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.

Authors:  Fanny Risser; Ivan Urosev; Joanan López-Morales; Yang Sun; Michael A Nash
Journal:  Biophys Rev       Date:  2022-04-06

8.  Hemostatic and Tissue Regeneration Performance of Novel Electrospun Chitosan-Based Materials.

Authors:  Volodymyr Deineka; Oksana Sulaieva; Mykola Pernakov; Viktoriia Korniienko; Yevheniia Husak; Anna Yanovska; Aziza Yusupova; Yuliia Tkachenko; Oksana Kalinkevich; Alena Zlatska; Maksym Pogorielov
Journal:  Biomedicines       Date:  2021-05-21

9.  Efficacy and Safety of Bioabsorbable Bone Hemostatic Agent in Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.

Authors:  Jong-Keun Kim; Du Hyun Ro; Sang-Min Han; Myung Chul Lee; Hyuk-Soo Han
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 10.  Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends.

Authors:  Horațiu Moldovan; Iulian Antoniac; Daniela Gheorghiță; Maria Sabina Safta; Silvia Preda; Marian Broască; Elisabeta Badilă; Oana Fronea; Alexandru Scafa-Udrişte; Mihai Cacoveanu; Adrian Molnar; Victor Sebastian Costache; Ondin Zaharia
Journal:  Polymers (Basel)       Date:  2022-03-16       Impact factor: 4.329

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.